DAWN TINGWALD: Open Payments
NPI 1083169270 · JEFFERSON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 7 payments from 6 companies in 2025. Trend: 2023 $113 · 2024 $174 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Amgen Inc. | 1 | $49 |
| Insulet Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, KRYSTEXXA, Omnipod, UBRELVY, Wegovy, ARISTADA.
Industry payments across IA — which companies pay providers there.
